Literature DB >> 23525115

Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor.

Keyang Chen1, Kevin Jon Williams.   

Abstract

Endocytosis via rafts has attracted considerable recent interest, but the molecular mediators remain incompletely characterized. Here, we focused on the syndecan-1 heparan sulfate proteoglycan, a highly conserved, multifunctional receptor that we previously showed to undergo raft-dependent endocytosis upon clustering. Alanine scanning mutagenesis of three to five consecutive cytoplasmic residues at a time revealed that a conserved juxtamembrane motif, MKKK, was the only region required for efficient endocytosis after clustering. Endocytosis of clustered syndecan-1 occurs in two phases, each requiring a kinase and a corresponding cytoskeletal partner. In the initial phase, ligands trigger rapid MKKK-dependent activation of ERK and the localization of syndecan-1 into rafts. Activation of ERK drives the dissociation of syndecan-1 from α-tubulin, a molecule that may act as an anchor for syndecan-1 at the plasma membrane in the basal state. In the second phase, Src family kinases phosphorylate tyrosyl residues within the transmembrane and cytoplasmic regions of syndecan-1, a process that also requires MKKK. Tyrosine phosphorylation of syndecan-1 triggers the robust recruitment of cortactin, which we found to be an essential mediator of efficient actin-dependent endocytosis. These findings represent the first detailed characterization of the molecular events that drive endocytosis of a raft-dependent receptor and identify a novel endocytic motif, MKKK. Moreover, the results provide new tools to study syndecan function and regulation during uptake of its biologically and medically important ligands, such as HIV-1, atherogenic postprandial remnant lipoproteins, and molecules implicated in Alzheimer disease.

Entities:  

Keywords:  ERK; Lipid Raft; Lipoprotein Receptor; Proteoglycan; Receptor Endocytosis; Src

Mesh:

Substances:

Year:  2013        PMID: 23525115      PMCID: PMC3656258          DOI: 10.1074/jbc.M112.444737

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  The syndecans, tuners of transmembrane signaling.

Authors:  P Zimmermann; G David
Journal:  FASEB J       Date:  1999       Impact factor: 5.191

2.  Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth.

Authors:  T Kinnunen; M Kaksonen; J Saarinen; N Kalkkinen; H B Peng; H Rauvala
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

Review 3.  Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism.

Authors:  K J Williams; I V Fuki
Journal:  Curr Opin Lipidol       Date:  1997-10       Impact factor: 4.776

4.  Major histocompatibility complex class I molecules mediate association of SV40 with caveolae.

Authors:  E Stang; J Kartenbeck; R G Parton
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

5.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.

Authors:  Kevin Jon Williams; Ming-Lin Liu; Yanqing Zhu; Xiangsheng Xu; William R Davidson; Peter McCue; Kumar Sharma
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 7.  Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins.

Authors:  Sue Goo Rhee; Sang Won Kang; Woojin Jeong; Tong-Shin Chang; Kap-Seok Yang; Hyun Ae Woo
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

8.  Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway.

Authors:  X Yang; D Gabuzda
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.

Authors:  J J Grootjans; P Zimmermann; G Reekmans; A Smets; G Degeest; J Dürr; G David
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

10.  Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells.

Authors:  A R Cohen; D F Woods; S M Marfatia; Z Walther; A H Chishti; J M Anderson; D F Wood
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  35 in total

1.  Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Authors:  G M Anantharamaiah; Dennis Goldberg
Journal:  Clin Lipidol       Date:  2015-01-01

Review 2.  Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour.

Authors:  John R Couchman; Sandeep Gopal; Hooi Ching Lim; Steffen Nørgaard; Hinke A B Multhaupt
Journal:  Int J Exp Pathol       Date:  2014-12-26       Impact factor: 1.925

3.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Authors:  Julia Elisa Sepulveda-Diaz; Seyedeh Maryam Alavi Naini; Minh Bao Huynh; Mohand Ouidir Ouidja; Constantin Yanicostas; Sandrine Chantepie; Joao Villares; Foudil Lamari; Estelle Jospin; Toin H van Kuppevelt; Ayikoe Guy Mensah-Nyagan; Rita Raisman-Vozari; Nadia Soussi-Yanicostas; Dulce Papy-Garcia
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

4.  Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.

Authors:  Elena E Korbolina; Nikita I Ershov; Leonid O Bryzgalov; Natalia G Kolosova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

Review 5.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

6.  SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

Authors:  H Carlijne Hassing; R Preethi Surendran; Bruno Derudas; An Verrijken; Sven M Francque; Hans L Mooij; Sophie J Bernelot Moens; Leen M 't Hart; Giel Nijpels; Jacqueline M Dekker; Kevin Jon Williams; Erik S G Stroes; Luc F Van Gaal; Bart Staels; Max Nieuwdorp; Geesje M Dallinga-Thie
Journal:  Obesity (Silver Spring)       Date:  2014-01-09       Impact factor: 5.002

7.  Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.

Authors:  Keyang Chen; Qingsi Wu; Kongwang Hu; Chengwei Yang; Xiangdong Wu; Peter Cheung; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

8.  Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Authors:  Bohee Jang; Hyejung Jung; Sojoong Choi; Young Hun Lee; Seung-Taek Lee; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

Review 9.  Syndecan-1 and Its Expanding List of Contacts.

Authors:  Mary Ann Stepp; Sonali Pal-Ghosh; Gauri Tadvalkar; Ahdeah Pajoohesh-Ganji
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

Review 10.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.